Clinical features of SARS-CoV-2 Omicron BA.2; Lessons from previous observations - Correspondence.
作者信息
Sahebi Saeed, Keikha Masoud
机构信息
Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
出版信息
Int J Surg. 2022 Aug;104:106754. doi: 10.1016/j.ijsu.2022.106754. Epub 2022 Jul 5.
Abstract
摘要
相似文献
1
Clinical features of SARS-CoV-2 Omicron BA.2; Lessons from previous observations - Correspondence.新型冠状病毒奥密克戎BA.2的临床特征；既往观察所得的经验教训——通信
Int J Surg. 2022 Aug;104:106754. doi: 10.1016/j.ijsu.2022.106754. Epub 2022 Jul 5.
2
Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.日本基于登记的观察性研究：COVID-19 症状与奥密克戎亚变体 BA.2 和 BA.5、宿主状态和临床结局的关联。
Lancet Infect Dis. 2023 Nov;23(11):1244-1256. doi: 10.1016/S1473-3099(23)00271-2. Epub 2023 Jun 30.
3
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections.保护 COVID-19 疫苗接种和既往感染对奥密克戎 BA.1、BA.2 和德尔塔 SARS-CoV-2 感染的作用。
Nat Commun. 2022 Aug 12;13(1):4738. doi: 10.1038/s41467-022-31838-8.
4
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月，英国青少年在先前感染和接种疫苗后对 delta（B.1.617.2）和 omicron（B.1.1.529）BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用：一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
5
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.导致 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 进入偏好改变的 Spike 突变。
Emerg Microbes Infect. 2022 Dec;11(1):2275-2287. doi: 10.1080/22221751.2022.2117098.
6
Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.新加坡一项全国性队列研究：SARS-CoV-2 感染和疫苗对有医疗记录的奥密克戎 BA.4、BA.5 和 XBB 再感染相关症状的保护免疫作用。
Lancet Infect Dis. 2023 Jul;23(7):799-805. doi: 10.1016/S1473-3099(23)00060-9. Epub 2023 Mar 13.
7
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
8
Significant neutralizing escapes of Omicron and its sublineages in SARS-CoV-2-infected individuals vaccinated with inactivated vaccines.在接种灭活疫苗的 SARS-CoV-2 感染个体中，奥密克戎及其亚谱系发生了显著的中和逃逸。
J Med Virol. 2023 Feb;95(2):e28516. doi: 10.1002/jmv.28516.
9
Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.中国天津地区针对 SARS-CoV-2 奥密克戎 BA.1 变异株疫苗突破性感染后五种 SARS-CoV-2 变异株的中和抗体反应和 T 淋巴细胞变化的前瞻性研究。
Biomed Environ Sci. 2023 Jul 20;36(7):614-624. doi: 10.3967/bes2023.047.
10
As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?随着 SARS-CoV-2 病毒的演变，奥密克戎亚变体 BA.2 是否应该被隔离，还是我们应该学会与之共存？
Front Public Health. 2022 Nov 24;10:1039123. doi: 10.3389/fpubh.2022.1039123. eCollection 2022.
引用本文的文献
1
Characteristics and outcomes of COVID-19 patients during the BA.5 omicron wave in Tehran, Iran: a prospective observational study.伊朗德黑兰 BA.5 奥密克戎波期间 COVID-19 患者的特征和结局：一项前瞻性观察研究。
BMC Infect Dis. 2023 Apr 17;23(1):237. doi: 10.1186/s12879-023-08181-4.
2
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?营养保健品对新冠病毒感染及新冠康复后的预防和治疗有效吗？
Foods. 2022 Sep 17;11(18):2884. doi: 10.3390/foods11182884.
本文引用的文献
1
Epidemiological and clinical features of SARS-CoV-2 Omicron variant infection in Quanzhou, Fujian province: a retrospective study.福建省泉州市 SARS-CoV-2 奥密克戎变异株感染的流行病学和临床特征：一项回顾性研究。
Sci Rep. 2023 Dec 13;13(1):22152. doi: 10.1038/s41598-023-49098-x.
2
Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data.基于 TaqMan 检测的 Omicron BA.1、BA.1.1 和 BA.2 亚谱系分类与全基因组分析数据一致。
Int J Infect Dis. 2022 Sep;122:486-491. doi: 10.1016/j.ijid.2022.06.039. Epub 2022 Jun 26.
3
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California.南加州与 SARS-CoV-2 奥密克戎（B.1.1.529）变异株以及 BA.1/BA.1.1 或 BA.2 亚变异株感染相关的临床结局。
Nat Med. 2022 Sep;28(9):1933-1943. doi: 10.1038/s41591-022-01887-z. Epub 2022 Jun 8.
4
Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.2022年1月至3月，意大利普利亚地区一个中心首批284例感染新型冠状病毒奥密克戎BA.2亚型患者的特征。
Vaccines (Basel). 2022 Apr 24;10(5):674. doi: 10.3390/vaccines10050674.
5
Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 - vigilance needed.致编辑的信：严重急性呼吸综合征冠状病毒2变种奥密克戎BA.2的流行病学——需保持警惕
Euro Surveill. 2022 Mar;27(13). doi: 10.2807/1560-7917.ES.2022.27.13.2200254.
6
Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022.2021 年 11 月 29 日至 2022 年 1 月 2 日丹麦 SARS-CoV-2 变异株奥密克戎 BA.2 亚谱系的分子流行病学。
Euro Surveill. 2022 Mar;27(10). doi: 10.2807/1560-7917.ES.2022.27.10.2200181.
7
Literature Review of Omicron: A Grim Reality Amidst COVID-19.奥密克戎的文献综述：新冠疫情下的严峻现实
Microorganisms. 2022 Feb 16;10(2):451. doi: 10.3390/microorganisms10020451.
Zotero 插件